Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

PSEUDOMONAS EXOTOXIN A-Like Chimeric Immunogens

  • Read more about PSEUDOMONAS EXOTOXIN A-Like Chimeric Immunogens
US Application 60/052,375
Filed on 1997-07-11

NUCLEIC ACID AND AMINO ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPO RTER AND METHODS OF SCREENING FOR AGENTS THAT MODIFY ATP-BINDING CASSE

  • Read more about NUCLEIC ACID AND AMINO ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPO RTER AND METHODS OF SCREENING FOR AGENTS THAT MODIFY ATP-BINDING CASSE
US Application 60/039,388
Filed on 1997-02-27

A UNIQUE TRANSACTIVATION SEQUENCE MOTIF AND REPRESSION DOMAIN OF FUSE BINDING PROTEIN AND TWO NOVEL FUSE BINDING PROTEINS AND cDNAs THEREFOR

  • Read more about A UNIQUE TRANSACTIVATION SEQUENCE MOTIF AND REPRESSION DOMAIN OF FUSE BINDING PROTEIN AND TWO NOVEL FUSE BINDING PROTEINS AND cDNAs THEREFOR
US Application 60/031,905
Filed on 1996-11-27

PEPTIDE ANTIGENS FOR IMMUNOTHERAPEUTIC TREATMENT AND/OR PREVENTION OF HIV

  • Read more about PEPTIDE ANTIGENS FOR IMMUNOTHERAPEUTIC TREATMENT AND/OR PREVENTION OF HIV
US Application 60/010,560
Filed on 1996-01-27

Generation Of Biomaterial Microarrays By Laser Transfer

  • Read more about Generation Of Biomaterial Microarrays By Laser Transfer
US Application 60/269,364
Filed on 2001-02-20

MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME

  • Read more about MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME
US Application 60/024,098
Filed on 1996-08-16

MODIFIED PSEUDOMONAS EXOTOXIN PROPROTEINS

  • Read more about MODIFIED PSEUDOMONAS EXOTOXIN PROPROTEINS
US Application 60/030,376
Filed on 1996-11-06

9-10InsC in 5'UTR May Be Useful Polymorphism in Identification of Melanoma Metastasis

  • Read more about 9-10InsC in 5'UTR May Be Useful Polymorphism in Identification of Melanoma Metastasis
US Application 60/422,821
Filed on 2002-10-31

VANILLOID AGONISTS AND DESENSITIZATION OF C-FIBER SENSORY AFFERENT NEURONS

  • Read more about VANILLOID AGONISTS AND DESENSITIZATION OF C-FIBER SENSORY AFFERENT NEURONS
US Application 60/030,999
Filed on 1996-11-15

IDENTIFICATION OF A VIRAL ETIOLOGY FOR B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD

  • Read more about IDENTIFICATION OF A VIRAL ETIOLOGY FOR B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD
US Application 60/036,991
Filed on 1997-01-30

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health